Pentavalent (DTaP-IPV+Hib) vaccine 2027-2028 (2029, 2030, 2031)

Pentavalent (DTaP-IPV+Hib) vaccine 2027-2028 (2029, 2030, 2031) The Ministry of Social Affairs and Health (later referred to as ”STM”) and the Finnish Institute for Health and Welfare (later referred to as "THL" or “Customer” ) request your tender for Diphtheria, tetanus, acellular pertussis, polio and Haemophilus influenzae type b (DTaP-IPV+Hib) vaccine, required for the vaccinations in the National Immunisation Program in Finland. The contract period is one (1) year during 2027 - 2028. The procurement contains three (3) one (1) -year contract period renewals (1 + 1 + 1) to extend the contract for the years 2029, 2030 and 2031. Estimated quantity for the contract period including contract period renewals is 560,000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%. The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The most economically advantageous Tender shall be a Tender with lowest price. Please note that all times given in the Call for Tender refer to local time in Finland. Call for Tenders, annexes: Annex 1 Contract Annex 2 JYSE 2025 SUPPLIES Annex 3 Delivery schedule Annex 4 Subcontractors Annex 5 Description of the Handi Service Annex 6 Bank Details Annex 7 Quality Agreement,